Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Motus GI is a medical technology company focused on developing and commercializing innovative endoscopy solutions to improve clinical outcomes and cost-efficiency in gastrointestinal (GI) procedures. The company's flagship product, the Pure-Vu System, is an FDA-cleared medical device designed to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and upper GI endoscopy. By providing real-time irrigation and evacuation of debris, the system enhances visualization for physicians, potentially reducing the need for repeat procedures and improving the detection of colorectal cancer and other GI conditions. Motus GI targets high-acuity hospital settings and outpatient endoscopy centers, aiming to establish its technology as a standard of care for patients with challenging bowel preparations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Motus.